SMI
11.937,42
PKT
-194,52
PKT
-1,60
%
Werbung
Analysen zu SMI-Werten
| Datum | Rating | Analyst | |
|---|---|---|---|
| 13.02.25 | Nestlé Neutral | UBS AG | |
| 13.02.25 | Nestlé Market-Perform | Bernstein Research | |
| 13.02.25 | Nestlé Buy | Goldman Sachs Group Inc. | |
| 13.02.25 | Nestlé Add | Baader Bank | |
| 13.02.25 | Nestlé Neutral | JP Morgan Chase & Co. | |
| 13.02.25 | Nestlé Underperform | Jefferies & Company Inc. | |
| 13.02.25 | Nestlé Outperform | RBC Capital Markets | |
| 13.02.25 | Novartis Neutral | UBS AG | |
| 12.02.25 | Novartis Buy | Deutsche Bank AG | |
| 11.02.25 | Novartis Neutral | Goldman Sachs Group Inc. | |
| 11.02.25 | ABB (Asea Brown Boveri) Underperform | Bernstein Research | |
| 11.02.25 | UBS Buy | Deutsche Bank AG | |
| 11.02.25 | Richemont Buy | UBS AG | |
| 11.02.25 | UBS Outperform | RBC Capital Markets | |
| 11.02.25 | ABB (Asea Brown Boveri) Neutral | Goldman Sachs Group Inc. | |
| 10.02.25 | Roche Sell | Goldman Sachs Group Inc. | |
| 10.02.25 | Roche Outperform | Bernstein Research | |
| 07.02.25 | UBS Halten | DZ BANK | |
| 07.02.25 | ABB (Asea Brown Boveri) Kaufen | DZ BANK | |
| 07.02.25 | UBS Overweight | JP Morgan Chase & Co. | |
| 06.02.25 | Nestlé Neutral | UBS AG | |
| 06.02.25 | Novartis Neutral | Goldman Sachs Group Inc. | |
| 06.02.25 | Roche Sell | Goldman Sachs Group Inc. | |
| 06.02.25 | UBS Buy | Goldman Sachs Group Inc. | |
| 05.02.25 | Zurich Insurance Hold | Deutsche Bank AG | |
| 05.02.25 | Nestlé Market-Perform | Bernstein Research | |
| 04.02.25 | Roche Sell | Deutsche Bank AG | |
| 04.02.25 | UBS Buy | Goldman Sachs Group Inc. | |
| 04.02.25 | UBS Hold | Deutsche Bank AG | |
| 04.02.25 | UBS Overweight | JP Morgan Chase & Co. | |
| 04.02.25 | Novartis Buy | Deutsche Bank AG | |
| 04.02.25 | UBS Outperform | RBC Capital Markets | |
| 04.02.25 | UBS Buy | Goldman Sachs Group Inc. | |
| 03.02.25 | Roche Underweight | JP Morgan Chase & Co. | |
| 03.02.25 | Novartis Hold | Deutsche Bank AG | |
| 03.02.25 | Novartis Kaufen | DZ BANK | |
| 03.02.25 | Nestlé Neutral | UBS AG | |
| 03.02.25 | Novartis Buy | UBS AG | |
| 31.01.25 | Roche Sell | Deutsche Bank AG | |
| 31.01.25 | Novartis Neutral | Goldman Sachs Group Inc. |
* Die angezeigten Realtime Kurse sind indikativ und nicht die offiziellen Börsenkurse. Die Kursdaten können eventuell vom tatsächlichen Marktpreis abweichen.